[ad_1]
[email protected]
To prevent Chronic Obstructive Pulmonary Disease (COPD) from becoming the third leading cause of death in 2020, scientists have developed a new treatment that reduces the complications of this disease by up to 25% and allows better quality of life. 19659002] Jesús Javier Vázquez Cortés, a member of the Mexican Society of Pneumology and Thoracic Surgery (SMNyCT), explains that the treatment consists of a triple therapy consisting of inhaled steroids and long-acting bronchodilators, which showed a reduction of up to 25%. at 25% the risk of moderate to severe complications, and in 34% those leading to hospitalization, which allows patients to improve their quality of life.
"This news is supported by the outcome of the multicenter and international study called IMPACT, conducted in 37 countries over the 52 weeks where more than 10,000 COPD patients and history of COPD occurred. exacerbations have participated, "he said. 002] At a press conference, he explained that smoking and constant exposure to wood smoke are the main risk factors for COPD, characterized by persistent obstruction of blood flow. air, a state that affects 251 millions of people around the world.
Source link
